Contrast Agent Contrast Medium Pediatric Radiology Sodium Iodide Nonionic Contrast Medium 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Swick, M (1978) Radiographic media in urology, the discovery of excretion urography. Surgical Clinics of North America 58: 977–994PubMedGoogle Scholar
  2. 2.
    Grainger RG, Thomas AMK (1999) History of the development of radiological contrast agents (1895–1996). In: Dawson P, Cosgrove DO, Grainger RG. Textbook of Contrast Media. Isis, Oxford. Pp3–14Google Scholar
  3. 3.
    Cameron D (1917) Aqueous solutions of potassium & sodium iodides as opaque media in roentgenography. J American Medical Association 70: 754–755Google Scholar
  4. 4.
    Osborne ED, Sutherland CG, Scholl AJ Jr, Rowntree LG (1923) Roentgenology of the urinary tract during excretion of sodium iodide. American Medical Association 80: 368–373Google Scholar
  5. 5.
    Swick M (1929) Darstellung der Niere und Harnwege in Roentgenbild durch intravenöse Einbringung eines neuen Kontraststoffes: des Uroselectans. Klinische Wochenschrift 8: 2087–2089CrossRefGoogle Scholar
  6. 6.
    Von Lichtenberg A, Swick M (1929) Klinische Prüfung des Uroselectans. Klinische Wochenschrift 8: 2089–2091CrossRefGoogle Scholar
  7. 7.
    Wallingford VH (1953) The development of organic iodide compounds as X-ray contrast media. Journal of American Pharmacological Association (Scientific Edition) 42: 721–728Google Scholar
  8. 8.
    Hoppe JO, Larsen HA, Coulston FJ (1956) Observations on the toxicity of a new urographic contrast medium, sodium 3,5-diacetamido-2, 4, 6 tri-iodobenzoate (Hypaque sodium) and related compounds. Journal of Pharmacological and Experimental Therapeutics 116: 394–403Google Scholar
  9. 9.
    Grainger RG (1982) Intravascular contrast media — the past, the present and the future. British Journal of Radiology 55: 1–18PubMedGoogle Scholar
  10. 10.
    Almén T (1969) Contrast agent design. Some aspects on the synthesis of water-soluble contrast agents of low osmolality. Journal of Theoretical Biology 24: 216–226PubMedGoogle Scholar
  11. 11.
    Amdam RP, Sogner K (1994) Wealth of contrasts. Oslo: Ad Notam GyldendalGoogle Scholar
  12. 12.
    Dawson P, Grainger RG, Pitfield J (1983) The new low-osmolar contrast media: a simple guide. Clinical Radiology 34: 221–226CrossRefPubMedGoogle Scholar
  13. 13.
    Dawson P, Saini S, Schild H, Niendorf HP, Schlieff R (1994) Continuing progress in contrast agents. Imaging 6: 273–284Google Scholar
  14. 14.
    Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. New England Journal of Medicine 348: 491–499CrossRefPubMedGoogle Scholar
  15. 15.
    Almén T (1985) Development of non-ionic contrast media. Investigative Radiology 20: 2–9PubMedGoogle Scholar
  16. 1.
    Weinmann HJ (1999) Gadolinium chelates: physico-chemical properties, formulation and toxicology. In: Dawson P, Cosgrove DO, Grainger RG. Textbook of Contrast Media. Isis, Oxford. pp 297–318Google Scholar
  17. 2.
    Lauterbur PC, Mendonça-Dias H, Rudin AM (1978) Augmentation of tissue proton spin-lattice relaxation rates by in vivo addition of paramagnetic ions. in: Dutton PO, Leigh J, Scarpa A (eds). Frontiers of Biological Energetics. New York: Academic Press pp 752–759Google Scholar
  18. 3.
    Haën C (2001) Conception of the first magnetic resonance imaging contrast agents: a brief history. Topics in Magnetic Resonance Imaging 12: 221–230CrossRefPubMedGoogle Scholar
  19. 4.
    Carr D, Brown I, Bydder G, Weinmann HJ, Speck U, Thomas DJ, Young IR (1984) Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet i: 484–486CrossRefGoogle Scholar
  20. 5.
    Weinmann HJ, Brasch RC, Press WR, Wesby GE (1984) Characteristics of gadolinium-DT-PA complex: a potential NMR contrast agent. AJR 142: 619–624PubMedGoogle Scholar
  21. 6.
    Brasch RC, Weinmann HJ, Wesbey GE (1984) Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. Am J Roentgenology 142: 625–630Google Scholar
  22. 7.
    Claussen C, Laniado M, Schörner W, et al. (1985) Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. Am J Neuroradiol 6: 669–674PubMedGoogle Scholar
  23. 8.
    Weinmann HJ (2003) History of MRI contrast media development, accompanied by Magnevist. 15 years of Magnevist, Satellite Symposium: ECR 2003Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations